European Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Απλή σελίδα τεκμηρίου
dc.contributor.authorMikhailidis, D. P.en
dc.contributor.authorElisaf, M.en
dc.contributor.authorRizzo, M.en
dc.contributor.authorBerneis, K.en
dc.contributor.authorGriffin, B.en
dc.contributor.authorZambon, A.en
dc.contributor.authorAthyros, V. G.en
dc.contributor.authorde Graaf, J.en
dc.contributor.authorMarz, W.en
dc.contributor.authorParhofer, K. G.en
dc.contributor.authorRini, G. B.en
dc.contributor.authorSpinas, G. A.en
dc.contributor.authorTomkin, G. H.en
dc.contributor.authorTselepis, A. D.en
dc.contributor.authorWierzbicki, A. S.en
dc.contributor.authorWinkler, K.en
dc.contributor.authorFlorentin, M.en
dc.contributor.authorLiberopoulos, E.en
dc.date.accessioned2015-11-24T16:58:01Z
dc.date.available2015-11-24T16:58:01Z
dc.identifier.issn1570-1611-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/10646
dc.rightsDefault Licence-
dc.subjectldlen
dc.subjectsubclassesen
dc.subjectatherosclerosisen
dc.subjectcardiovascular risken
dc.subjectstatementen
dc.subjectcoronary-artery-diseaseen
dc.subjectcholesteryl ester transferen
dc.subjectfamilial combined hyperlipidemiaen
dc.subjecttype-2 diabetes-mellitusen
dc.subjectnuclear-magnetic-resonanceen
dc.subjectvery-low-densityen
dc.subjectapolipoprotein-b metabolismen
dc.subjectintima-media thicknessen
dc.subjectischemic-heart-diseaseen
dc.subjectc-reactive proteinen
dc.titleEuropean Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclassesen
heal.abstractAim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density lipoproteins (LDL) subclasses. We sub-divided our Statement in 2 sections: section I discusses the pathophysiology, atherogenicity and measurement issues, while section II is focused on the effects of drugs and lifestlyle modifications. Suggestions for future research in the field are highlighted at the end of section II. Each section includes Conclusions.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondary<Go to ISI>://000295413500002-
heal.journalNameCurr Vasc Pharmacolen
heal.journalTypepeer reviewed-
heal.languageen-
heal.publicationDate2011-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ